However, the physiological changes that support weight lossincluding delayed gastric emptying, reduced appetite, and improved glycaemic controlbegin to reverse as drug levels decline
Bone and muscle loss: The combination of reduced appetite and weight loss can lead to reduced muscle mass and bone density over time, especially when paired with inadequate protein intake and absence of strength training
H., Jabbour, S., & Rosenstock, J
By month three, a clear separation emerges, with compounded users demonstrating significantly lower continuation rates
While AUA does not yet explicitly mention GLP-1 agonists, the emerging evidence (below) suggests these agents could play a role in improving metabolic hypogonadism and should be considered in consultation with endocrinologists for obese men with fertility issues
According to the Summary of Product Characteristics (SmPCs), dysgeusia (altered taste) is listed as an uncommon side effect (affecting fewer than 1 in 100 but more than 1 in 1,000 people) for oral semaglutide (Rybelsus)